128 related articles for article (PubMed ID: 27821347)
21. Simplified quantification of cerebral A1 adenosine receptors using [18F]CPFPX and PET: analyses based on venous blood sampling.
Meyer PT; Elmenhorst D; Zilles K; Bauer A
Synapse; 2005 Mar; 55(4):212-23. PubMed ID: 15668990
[TBL] [Abstract][Full Text] [Related]
22. A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humans.
Meyer PT; Elmenhorst D; Matusch A; Winz O; Zilles K; Bauer A
Neuroimage; 2006 Sep; 32(3):1100-5. PubMed ID: 16806981
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine.
Kimura Y; Ishii K; Fukumitsu N; Oda K; Sasaki T; Kawamura K; Ishiwata K
Nucl Med Biol; 2004 Nov; 31(8):975-81. PubMed ID: 15607479
[TBL] [Abstract][Full Text] [Related]
24. Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study.
Elmenhorst D; Meyer PT; Winz OH; Matusch A; Ermert J; Coenen HH; Basheer R; Haas HL; Zilles K; Bauer A
J Neurosci; 2007 Feb; 27(9):2410-5. PubMed ID: 17329439
[TBL] [Abstract][Full Text] [Related]
25. Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans.
Meyer PT; Elmenhorst D; Boy C; Winz O; Matusch A; Zilles K; Bauer A
Neurobiol Aging; 2007 Dec; 28(12):1914-24. PubMed ID: 16996650
[TBL] [Abstract][Full Text] [Related]
26. Effects of Long-Term Caffeine Consumption on the Adenosine A
Nabbi-Schroeter D; Elmenhorst D; Oskamp A; Laskowski S; Bauer A; Kroll T
Mol Imaging Biol; 2018 Apr; 20(2):284-291. PubMed ID: 28895043
[TBL] [Abstract][Full Text] [Related]
27. In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography.
Bauer A; Holschbach MH; Meyer PT; Boy C; Herzog H; Olsson RA; Coenen HH; Zilles K
Neuroimage; 2003 Aug; 19(4):1760-9. PubMed ID: 12948730
[TBL] [Abstract][Full Text] [Related]
28. Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease.
Fukumitsu N; Ishii K; Kimura Y; Oda K; Hashimoto M; Suzuki M; Ishiwata K
Ann Nucl Med; 2008 Dec; 22(10):841-7. PubMed ID: 19142702
[TBL] [Abstract][Full Text] [Related]
29. Adenosine A1 receptor mapping of the human brain by PET with 8-dicyclopropylmethyl-1-11C-methyl-3-propylxanthine.
Fukumitsu N; Ishii K; Kimura Y; Oda K; Sasaki T; Mori Y; Ishiwata K
J Nucl Med; 2005 Jan; 46(1):32-7. PubMed ID: 15632030
[TBL] [Abstract][Full Text] [Related]
30. Imaging of adenosine A1 receptors in the human brain by positron emission tomography with [11C]MPDX.
Fukumitsu N; Ishii K; Kimura Y; Oda K; Sasaki T; Mori Y; Ishiwata K
Ann Nucl Med; 2003 Sep; 17(6):511-5. PubMed ID: 14575390
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.
Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S
Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of the main metabolite in human blood of the A1 adenosine receptor ligand [18F]CPFPX.
Holschbach MH; Bier D; Wutz W; Willbold S; Olsson RA
Org Lett; 2009 Oct; 11(19):4266-9. PubMed ID: 19725521
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands.
Bansal R; Kumar G; Rohilla S; Klotz KN; Kachler S; Young LC; Harvey AL
Drug Dev Res; 2016 Aug; 77(5):241-50. PubMed ID: 27404511
[TBL] [Abstract][Full Text] [Related]
34.
Joya A; Ardaya M; Montilla A; Garbizu M; Plaza-García S; Gómez-Vallejo V; Padro D; Gutiérrez JJ; Rios X; Ramos-Cabrer P; Cossío U; Pulagam KR; Higuchi M; Domercq M; Cavaliere F; Matute C; Llop J; Martín A
Theranostics; 2021; 11(1):410-425. PubMed ID: 33391483
[TBL] [Abstract][Full Text] [Related]
35. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats.
Olberg DE; Bauer N; Andressen KW; Hjørnevik T; Cumming P; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL
Nucl Med Biol; 2016 Aug; 43(8):478-89. PubMed ID: 27236283
[TBL] [Abstract][Full Text] [Related]
36. Cerebral A
Pierling AL; Elmenhorst EM; Lange D; Hennecke E; Baur DM; Beer S; Kroll T; Neumaier B; Aeschbach D; Bauer A; Landolt HP; Elmenhorst D
Neuroimage; 2021 Dec; 245():118695. PubMed ID: 34732326
[TBL] [Abstract][Full Text] [Related]
37. Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis.
Boy C; Meyer PT; Kircheis G; Holschbach MH; Herzog H; Elmenhorst D; Kaiser HJ; Coenen HH; Haussinger D; Zilles K; Bauer A
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):589-97. PubMed ID: 18000666
[TBL] [Abstract][Full Text] [Related]
38. Cognitive impairments by alcohol and sleep deprivation indicate trait characteristics and a potential role for adenosine A
Elmenhorst EM; Elmenhorst D; Benderoth S; Kroll T; Bauer A; Aeschbach D
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):8009-8014. PubMed ID: 30012607
[TBL] [Abstract][Full Text] [Related]
39. Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A
Harmse R; van der Walt MM; Petzer JP; Terre'Blanche G
Bioorg Med Chem Lett; 2016 Dec; 26(24):5951-5955. PubMed ID: 27836398
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
